Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-023932
Filing Date
2025-05-08
Accepted
2025-05-08 17:28:47
Documents
82
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q whwk-20250331.htm   iXBRL 10-Q 1544395
2 EX-10.1 exhibit101-amendment1toint.htm EX-10.1 20568
3 EX-10.2 exhibit102-amendmentno1tos.htm EX-10.2 53159
4 EX-31.1 whwk-20250331xex311.htm EX-31.1 10959
5 EX-31.2 whwk-20250331xex312.htm EX-31.2 10792
6 EX-32.1 whwk-20250331xex321.htm EX-32.1 5171
7 EX-32.2 whwk-20250331xex322.htm EX-32.2 5145
  Complete submission text file 0001628280-25-023932.txt   7832375

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT whwk-20250331.xsd EX-101.SCH 52367
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT whwk-20250331_cal.xml EX-101.CAL 74765
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT whwk-20250331_def.xml EX-101.DEF 288072
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT whwk-20250331_lab.xml EX-101.LAB 719416
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT whwk-20250331_pre.xml EX-101.PRE 506937
85 EXTRACTED XBRL INSTANCE DOCUMENT whwk-20250331_htm.xml XML 858422
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 25927539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)